{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:03:52Z","timestamp":1784545432303,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR000117"],"award-info":[{"award-number":["UL1 TR000117"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 DA17548"],"award-info":[{"award-number":["U19 DA17548"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 DA05312"],"award-info":[{"award-number":["P50 DA05312"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 DA016176"],"award-info":[{"award-number":["T32 DA016176"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24AA015512"],"award-info":[{"award-number":["U24AA015512"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.drugalcdep.2018.09.008","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T16:01:30Z","timestamp":1539792090000},"page":"154-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic \u03b16\u03b22* antagonist r-bPiDI"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0410-7887","authenticated-orcid":false,"given":"Sarah E.","family":"Maggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith A.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3466-9912","authenticated-orcid":false,"given":"Kimberly","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangrong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda P.","family":"Dwoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Bardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0005","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1530-0277.2008.00633.x","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist?","volume":"32","author":"Baros","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0010","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s11064-015-1680-4","article-title":"r-bPiDI, an alpha6beta2* nicotinic receptor antagonist, decreases nicotine-evoked dopamine release and nicotine reinforcement","volume":"40","author":"Beckmann","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/bs.irn.2016.02.017","article-title":"A genetic animal model of alcoholism for screening medications to treat addiction","volume":"126","author":"Bell","year":"2016","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pbb.2011.07.017","article-title":"Modeling binge-like ethanol drinking by peri-adolescent and adult P rats","volume":"100","author":"Bell","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pbb.2012.07.007","article-title":"Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity","volume":"103","author":"Bell","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0030","series-title":"The Motivational Impact of Nicotine and Its Role in Tobacco Use","author":"Bevins","year":"2009"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00589894","article-title":"Nicotine maintains robust self-administration in rats on a limited-access schedule","volume":"99","author":"Corrigall","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02244173","article-title":"Opiate antagonists reduce cocaine but not nicotine self-administration","volume":"104","author":"Corrigall","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/acer.13562","article-title":"The effects of long-term varenicline administration on ethanol and sucrose seeking and self-administration in male P rats","volume":"42","author":"Czachowski","year":"2018","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0050","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/acer.12854","article-title":"Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial","volume":"39","author":"de Bejczy","year":"2015","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00213-005-0054-z","article-title":"Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone","volume":"184","author":"DeNoble","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.alcohol.2011.08.011","article-title":"Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats","volume":"46","author":"Dhaher","year":"2012","journal-title":"Alcohol"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0065","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/ntr\/ntw123","article-title":"Varenicline for smoking cessation in light smokers","volume":"18","author":"Ebbert","year":"2016","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.08.023","article-title":"Sex and gender-related differences in alcohol use and its consequences: contemporary knowledge and future research considerations","volume":"156","author":"Erol","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0075","first-page":"162","article-title":"An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"29","author":"Falk","year":"2006","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2125.1985.tb02637.x","article-title":"Nicotine pharmacokinetics and its application to intake from smoking","volume":"19","author":"Feyerabend","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0085","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1111\/acer.12513","article-title":"Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking","volume":"38","author":"Fridberg","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0090","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/acer.13432","article-title":"Varenicline reduces alcohol intake during repeated cycles of alcohol reaccess following deprivation in alcohol-preferring (P) rats","volume":"41","author":"Froehlich","year":"2017","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0095","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.biopsych.2012.03.023","article-title":"Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence","volume":"72","author":"Fucito","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbr.2015.09.009","article-title":"Effects of varenicline on operant self-administration of alcohol and\/or nicotine in a rat model of co-abuse","volume":"296","author":"Funk","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00213-010-2024-3","article-title":"Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration","volume":"213","author":"George","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s002130050153","article-title":"An oral self-administration model of nicotine preference in rats: effects of mecamylamine","volume":"128","author":"Glick","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pharmthera.2003.08.004","article-title":"Advances in nonhuman primate alcohol abuse and alcoholism research","volume":"100","author":"Grant","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0125","first-page":"S279","article-title":"Varenicline reduces nicotine self-administration, naltrexone inhibits alcohol consumption, but both fail to alter concurrent ethanol and nicotine self-administration","volume":"43","author":"Hauser","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0130","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","article-title":"Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms","volume":"111","author":"Heilig","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0135","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1007\/s00213-014-3571-9","article-title":"Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats","volume":"231","author":"Henderson-Redmond","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brainresbull.2017.07.020","article-title":"Varenicline modulates ethanol and saccharin consumption in adolescent male and female C57BL\/6J mice","volume":"138","author":"Kamens","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0145","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1530-0277.2009.00925.x","article-title":"Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study","volume":"33","author":"King","year":"2009","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0150","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1007\/s00213-014-3541-2","article-title":"Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse","volume":"231","author":"L\u00ea","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0893-133X(99)00024-X","article-title":"Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress","volume":"21","author":"L\u00ea","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0160","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00213-018-4853-4","article-title":"Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats","volume":"235","author":"Maggio","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.alcohol.2013.09.044","article-title":"The alcohol-preferring (P) and high-alcohol-drinking (HAD) rats\u2014animal models of alcoholism","volume":"48","author":"McBride","year":"2014","journal-title":"Alcohol"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00213-007-0952-3","article-title":"Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration","volume":"196","author":"McKee","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0175","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/ntr\/ntv207","article-title":"Sex differences in varenicline efficacy for smoking cessation: a meta-analysis","volume":"18","author":"McKee","year":"2016","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0180","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up","volume":"166","author":"Nides","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/dmd.105.006767","article-title":"Metabolism and disposition of varenicline, a selective \u03b14\u03b22 acetylcholine receptor partial agonist, in vivo and in vitro","volume":"34","author":"Obach","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0190","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.drugalcdep.2013.06.019","article-title":"Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence","volume":"133","author":"Plebani","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40429-016-0081-3","article-title":"Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers","volume":"3","author":"Roche","year":"2016","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0200","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","article-title":"Pharmacological profile of the \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid","volume":"52","author":"Rollema","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0205","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-005-0250-x","article-title":"Nicotine and nonnicotine factors in cigarette addiction","volume":"184","author":"Rose","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/clpt.1994.105","article-title":"Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone","volume":"56","author":"Rose","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0215","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1007\/s00213-014-3518-1","article-title":"Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals","volume":"231","author":"Schacht","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0220","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cpr.2009.06.003","article-title":"Gender differences in factors influencing alcohol use and drinking progression among adolescents","volume":"29","author":"Schulte","year":"2009","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2015.09.002","article-title":"Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats","volume":"156","author":"Scuppa","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0230","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s002130050954","article-title":"Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats","volume":"143","author":"Shoaib","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0235","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.jhh.1001416","article-title":"Mecamylamine (Inversine): an old antihypertensive with new research directions","volume":"16","author":"Shytle","year":"2002","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0240","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/npp.2010.15","article-title":"Long-Evans rats acquire operant self-administration of 20% ethanol without sucrose fading","volume":"35","author":"Simms","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0245","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1007\/s11064-016-2045-3","article-title":"The nicotinic alpha6-subunit selective antagonist bPiDI reduces alcohol self-administration in alcohol-preferring rats","volume":"41","author":"Srisontiyakul","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0250","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1073\/pnas.0705368104","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking","volume":"104","author":"Steensland","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0255","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2850.2010.01674.x","article-title":"Nicotine dependence and gender differences in smokers accessing community mental health services","volume":"18","author":"Torchalla","year":"2011","journal-title":"J. Psychiatr. Mental Health Nurs."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0260","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1521-0391.2013.12014.x","article-title":"A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self-administration","volume":"22","author":"Udo","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0265","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ADM.0000000000000208","article-title":"Effect of lowering the dose of varenicline on alcohol self-administration in drinkers with alcohol use disorders","volume":"10","author":"Verplaetse","year":"2016","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0270","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.alcohol.2008.11.003","article-title":"Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection","volume":"43","author":"Williams","year":"2009","journal-title":"Alcohol"},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0275","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1476-5381.2011.01220.x","article-title":"bPiDI: A novel selective alpha6beta2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse","volume":"163","author":"Wooters","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.09.008_bib0280","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.3390\/ijerph7093406","article-title":"Human blood concentrations of cotinine, a biomonitoring marker for tobacco smoke, extrapolated from nicotine metabolism in rats and humans and physiologically based pharmacokinetic modeling","volume":"7","author":"Yamazaki","year":"2010","journal-title":"Int. J. Environ. Res. Public Health"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618307403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618307403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T22:48:43Z","timestamp":1542062923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618307403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":56,"alternative-id":["S0376871618307403"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.09.008","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic \u03b16\u03b22* antagonist r-bPiDI","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}